台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    101.0
  • 漲跌
    ▲0.5
  • 漲幅
    +0.50%
  • 成交量
    25
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元富-永和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-永和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/110103.0000.00101.5001560.02%
2024/06/071102.5000.00102.5011550.64%
2024/05/301102.501102.50102.5001590.00%
2024/05/271103.0000.00102.5011580.63%
2024/05/151103.0000.00104.0011480.67%
2024/05/141101.502100.50102.00-1144-0.69%
2024/05/1300.001107.00107.00-1127-0.76%
2024/05/100119.0000.00118.5001200.02%
2024/04/192117.0000.00116.0021131.77%
2024/04/1800.001117.00117.00-1112-0.89%
2024/04/1600.000.3115.00114.00-0.3111-0.27%
2024/04/110.3119.5000.00119.500.31010.29%
2024/03/190123.0000.00123.000550.04%
2024/02/221112.0000.00112.001323.12%
2024/02/150111.5000.00112.000310.08%
2024/01/150112.0000.00112.500290.09%
2023/12/200114.0000.00114.500230.11%
2023/12/111113.5000.00113.501214.56%
2023/11/150113.5000.00113.500200.13%
2023/10/190117.0000.00117.000240.10%
2023/10/170117.0000.00117.000240.01%
2023/09/150113.5000.00114.000260.10%
2023/08/180110.0000.00110.000310.00%
2023/08/150111.0000.00112.000300.09%
2023/08/101112.5000.00112.501303.33%
2023/07/282114.7500.00115.002326.18%
2023/07/170108.0000.00108.000290.09%
2023/07/060.3108.0000.00107.500.3420.63%
2023/06/150109.0000.00109.000550.05%
2023/05/160107.5000.00107.500550.03%
2023/05/150107.5000.00107.500550.01%
2023/05/120.2107.0000.00106.500.2550.36%
2023/04/281108.5000.00109.501521.89%
2023/04/251109.5000.00109.001521.89%
2023/04/140.3112.0000.00111.000.3500.68%
2023/04/1300.001118.00119.50-147-2.09%
2023/04/071119.0000.00119.501362.73%
2023/03/312117.7500.00118.002355.60%
2023/02/241108.5000.00109.001362.77%
2023/02/020.5108.5000.00107.500.5391.27%
2022/11/2400.000.1101.00101.00-0.124-0.21%
2022/10/1400.003103.67105.00-314-20.36%
2022/10/1300.001104.00104.00-115-6.30%
2022/07/2000.002111.00112.00-243-4.56%
2022/07/111100.5000.00100.501422.35%
2022/06/082100.5000.00100.502454.44%
2022/03/2100.002131.50132.00-219-10.40%
2021/12/081125.5000.00125.501283.45%
2021/11/111124.0000.00124.001293.37%
2021/10/061140.0000.00140.001342.86%
2021/08/041144.0000.00144.001362.72%
2021/07/291151.5000.00152.001323.03%
2021/06/1500.001156.00155.00-146-2.14%
2021/03/0400.000.4129.00129.00-0.426-1.50%
2021/03/0300.005129.00129.00-526-18.98%
2021/02/2400.005127.00126.00-526-18.96%
2021/02/2200.005125.50125.50-526-18.58%
2020/08/1400.001107.50107.50-156-1.77%
2020/06/0800.001114.00113.50-156-1.76%
2020/05/1900.000.1107.00107.00-0.151-0.19%
2020/05/1100.001107.50106.00-144-2.24%
2020/04/0900.001100.50100.00-142-2.33%
2020/04/0600.00198.6096.80-142-2.34%
2020/01/0900.001102.00102.00-123-4.21%
2019/12/300.1102.0000.00102.000.1200.62%
2019/10/141101.5000.00101.501253.92%
2019/07/301103.0000.00102.001452.18%
2018/04/162125.5000.00125.0021621.23%
2018/04/0200.0010132.00129.50-10162-6.16%
2018/03/291128.0000.00128.5011610.62%
2018/03/2000.002127.00127.50-2178-1.12%
2018/03/0524121.2100.00120.002417613.57%
2018/02/272117.5000.00117.0021721.16%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音